[ Price : $8.95]
FDA grants Human Genome Sciences a priority review for its BLA on Benlysta (belimumab) for treating systemic lupus erythematosus.[ Price : $8.95]
Federal Register Notice: FDA seeks comments on communication studies for CVM-regulated products.[ Price : $8.95]
FDA clears a Fenwal 510(k) for a new software release for its Autopheresis-C system used to collect plasma from donors.[ Price : $8.95]
HHS releases a report calling for more resources for FDA to approve new medical countermeasure drugs, vaccines, and devices more q...[ Price : $8.95]
Federal Register Notice: FDA plans a public meeting 2/9/10 on incorporating new science into regulatory decisionmaking within CDRH...[ Price : $8.95]
ISTA Pharmaceuticals submits a supplemental NDA for once-daily bromfenac ophthalmic solution as a treatment for ocular inflammatio...[ Price : $8.95]
FDA approves Boehringer Ingelheim Pharmaceuticals Spiriva HandiHaler (tiotropium bromide inhalation powder) for reducing exacerbat...[ Price : $8.95]
Attorney Arnold Friede says that drug companies need to be aware of the rules that CDERs DDMAC applies when evaluating presentatio...